Date: | 10/20/2023 |
Categories: | Academia Omics , Pharma CRO , SCIEX OS , MetabolitePilot Software |
For research use only. Not for use in diagnostic procedures.
Answer
The antibody drug conjugate (ADC) workflow in Molecular Profiler software 1.3 helps to identify and further characterize cytotoxic drugs, their breakdown products and the linker connected to the entire antibody sequence.
ADCs are designed for targeted delivery of a cytotoxic molecule to diseased or cancerous tissue. ADCs are composed of three components: the antibody used for selective targeting, the cytotoxic drug, and a linker connecting the two. The following steps describe how to set up the processing parameters for the ADC workflow:
Step1: Select the Processing Parameters tile after launching the Molecule Profiler software.
When using a targeted approach for the ADC workflow, the full amino acid sequences for the drug, its linker and the protein are required.
Step 2: Under the processing parameters window, create a new workflow by selecting ADC from the New menu.
Step 3: Enter the cytotoxic drug or payload and linker as a MOL file using the Open Structure button as shown below.
In the example above, the structure of the cytotoxic drug and its linker are shown, where the site of attachment to the antibody – the OH group – is shown in bold and circled in orange. Users must select the site of attachment using their mouse to encircle the functional group, which will then become bolded. Users must then right click on the bolded chemical group to bring up a pop up menu with additional options. “Mark as site of attachment” is one of the options, and once the user marks this site of attachment it will turn purple as shown in the screenshot (see orange circle).
Step 4: Complete the Antibody Details tab under Compound-Specific Parameters tab.
Posted: now